NFE2L2 and lung cancer: PSAT1 is a known target in NFE2L2/KEAP1 mutant lung cancer cell lines and was elevated in lung cancer and PDX tissues compared to adjacent lung tissues, suggesting serine biosynthesis could be an attractive target in SCC30,43.